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Abstract
Background: Six previous studies have examined the relationships between single nucleotide polymorphisms
(SNPs) in the IL13 gene and allergic rhinitis, but the results have been inconsistent. However, a recent meta-analysis
using data from these 6 studies has shown that the A allele of IL13 SNP rs20541 was associated with an increased
risk of allergic rhinitis, whereas no such relationship existed between IL13 SNP rs1800925 and allergic rhinitis. We
investigated the associations between IL13 SNPs rs1800925 and rs20541 and the risk of rhinoconjunctivitis in
Japanese women.
Methods: Included were 393 cases who met the criteria of the International Study of Asthma and Allergies in
Childhood (ISAAC) for rhinoconjunctivitis. Control subjects were 767 women without rhinoconjunctivitis according
to the ISAAC criteria, who had also not been diagnosed with allergic rhinitis by a doctor. Adjustment was made for
age, region of residence, presence of older siblings, smoking, family history of allergic rhinitis, and education.
Results: Compared with the GG genotype of IL13 SNP rs20541, the AA genotype, occurring in 7.1% of control
subjects, was significantly positively related to the risk of rhinoconjunctivitis: the adjusted odds ratio was 1.65 (95%
confidence interval: 1.05 - 2.60). SNP rs1800925 was not associated with rhinoconjunctivitis. The haplotype
comprising the rs1800925 C allele and the rs20541 A allele was significantly positively related to rhinoconjunctivitis.
The multiplicative interactions between the two SNPs under study and smoking on the risk of rhinoconjunctivitis
were not statistically significant. Based on the recessive model, however, the additive interaction between SNP
rs1800925, but not rs20541, and smoking was significant.
Conclusions: This study suggests that the minor genotype of IL13 SNP rs20541 and the CA haplotype are
significantly positively associated with the risk of rhinoconjunctivitis. In addition, a new pattern of biological
interaction that affects the risk of rhinoconjunctivitis is described between SNP rs1800925 and smoking.
Background
Allergic rhinitis is the most common allergic condition in
Japan. One study of 1540 Japanese aged 20 to 49 years
showed that the prevalence of allergic rhinitis was 44.2%
and that 89.6% of the subjects with allergic rhinitis were
sensitized to Japanese cedar pollen [1]. In a nationwide
survey in Japan, the age-adjusted prevalence of Japanese
cedar pollinosis was 19.4%; the prevalence was higher in
urban areas than in rural areas [2]. The development of
allergic rhinitis entails an interplay between genetic pre-
disposition and a range of environmental exposures.
Interleukin (IL)-13 is a critical mediator in the patho-
genesis of allergic inflammation [3]. One study has
revealed increased expression of the IL-13 gene in the
epithelial compartment of the nasal mucosa of patients
with perennial allergic rhinitis, and no such increase in
the nasal epithelial compartment of control subjects [4]. * Correspondence: miyake-y@fukuoka-u.ac.jp
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region. A recent meta-analysis incorporating 6 indepen-
dent studies of children and adults [5-10] reported that
the A allele of IL13 single nucleotide polymorphism (SNP)
rs20541 (Arg110/130Glu) in the coding region of exon 4
was associated with an increased risk of allergic rhinitis
whereas IL13 SNP rs1800925 (-1024C/T) in the promoter
region was not related to the risk of allergic rhinitis [11]. It
should be noted, however, that the 6 studies included in
that meta-analysis provided inconsistent results [5-10].
Here, we conducted a case-control study to investigate
the relationships between IL13 SNPs rs1800925 and
rs20541 and the risk of rhinoconjunctivitis in Japanese
women using data from the Kyushu Okinawa Maternal
and Child Health Study (KOMCHS). In addition, we car-
ried out haplotype analyses and examined the possibility
of an interaction between the SNPs and smoking. IL-13
production has been shown to be significantly greater in
smokers than in non-smokers [12]. A significant interac-
tion was observed between SNP rs1800925 and smoking,
with allergy as its outcome, in UK adults [5].
Methods
Study Population
The KOMCHS is an ongoing prospective prebirth cohort
study that investigates preventive and risk factors for
maternal and child health problems such as allergic disor-
ders. From April 2007 to March 2008, the KOMCHS
requested that 131 obstetric hospitals in Fukuoka Prefec-
ture, the largest prefecture on Kyushu Island in southern
Japan, with a total population of approximately 5.04 mil-
lion, provide as many pregnant women as possible with a
set of leaflets explaining the KOMCHS, an application to
participate in the study, and a self-addressed stamped
envelope in which to return the application. From May
2007 to March 2008, the KOMCHS also requested that 40
obstetric hospitals in Okinawa Prefecture, one of the
southernmost islands of Japan, with a total population of
almost 1.37 million, provide as many pregnant women as
possible with a comparable set of documents. Later, to
increase the sample size, pregnant women living in 6 pre-
fectures on Kyushu Island other than Fukuoka Prefecture,
with a total population of approximately 8.22 million,
were provided with comparable documents at 252 obste-
tric hospitals between August 2007 and March 2008. Preg-
nant women who intended to participate in the KOMCHS
returned the application form to the data management
center. By the end of the baseline study, a total of 1757
pregnant women between the 5th and 39th week of preg-
nancy had given their fully informed consent in writing to
participate in the KOMCHS and had completed the base-
line survey. Around four months after delivery, 1492
women gave informed consent to genotyping. The ethics
committee of the Faculty of Medicine, Fukuoka University,
approved the KOMCHS.
Selection of Cases and Control Subjects
In the baseline survey, each participant filled out a self-
administered questionnaire and mailed the completed
questionnaire to the data management center. Research
technicians completed missing or illogical data by tele-
phone interview.
The questionnaire included questions on rhinoconjunc-
tivitis based on the International Study of Asthma and
Allergies in Childhood (ISAAC) [13]. The presence of rhi-
noconjunctivitis was defined as a positive response to the
following 2 questions: ‘In the last 12 months, have you had
a problem with sneezing or a runny or blocked nose when
you did not have a cold or flu?’ and ‘In the last 12 months,
has this nose problem been accompanied by itchy-watery
eyes?’ The questionnaire also elicited information on age,
region of residence, presence of older siblings, smoking
habits, family history of allergic rhinitis, and education.
A history of smoking was defined as having smoked at
least once per day for at least one year. A family history of
allergic rhinitis (including Japanese cedar pollinosis) was
considered to be present if one or more parents or siblings
of the study subjects had been diagnosed with allergic rhi-
nitis by a physician.
By this definition, there were 393 cases of rhinocon-
junctivitis among the 1492 participants whose DNA
samples were available. Among the remaining partici-
pants, who would serve as control subjects, 331 women
were excluded who were not considered to have rhino-
conjunctivitis as defined by the ISAAC criteria but who
had answered ‘yes’ to the question: ‘Have you ever been
diagnosed by a physician as having allergic rhinitis?’.
Incomplete data on smoking caused the exclusion of 1
additional woman. In the end, 767 participants were
identified as control subjects for our analysis.
We also performed a sensitivity analysis restricted to the
293 cases with doctor-diagnosed allergic rhinitis out of the
393 cases considered to have rhinoconjunctivitis based on
the ISAAC criteria.
DNA Extraction and Genotyping
Research technicians or subjects themselves collected
buccal specimens with BuccalAmp swabs (Epicenter Bio-
Technologies, Madison, WI, USA). Genomic DNA was
extracted using a QIAmp DNA mini kit (Qiagen, Inc.,
Valencia, CA, USA). Two SNPs from the IL13 gene were
used in this study: rs1800925 in the 5’ promoter region
and rs20541 in exon 4. Genotyping of the two IL13 poly-
morphisms was performed using pre-development Taq-
Man SNP Genotyping Assays (Applied Biosystems,
Foster City, CA, USA). Information on SNP rs20541 in
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fication was impossible.
Statistical Analysis
Deviation from the Hardy-Weinberg equilibrium among
control subjects was evaluated by the chi-square test. Link-
age disequilibrium was investigated using Haploview soft-
ware version 4.1 [14]. Estimations of crude odds ratios
(ORs) and 95% confidence intervals (CIs) for rhinocon-
junctivitis in relation to the SNPs under study were made
by means of logistic regression analysis under additive
(Model 1) and dominant (Model 2) models. Multiple logis-
tic regression analysis was used to adjust for age, region of
residence, presence of older siblings, smoking, family his-
tory of allergic rhinitis, and education. The presence of
older siblings was significantly associated with a lower pre-
valence of rhinoconjunctivitis in this population [15]. Hap-
lotypes and their frequencies were inferred with the
expectation maximization (EM) algorithm. For differences
in haplotype frequency between the case and control
groups, crude ORs and 95% CIs were estimated based on
the frequency of each haplotype relative to all other haplo-
types combined. The multiplicative interaction was esti-
mated by introducing a multiplicative term into a multiple
logistic regression model. Three measures were used to
test the additive interaction [16]: 1) relative excess risk due
to interaction (RERI), 2) attributable proportion due to
interaction (AP), and 3) synergy index (S). RERI is the
excess risk due to an interaction relative to the risk with-
out exposure. AP refers to the attributable proportion of
disease that is due to an interaction among individuals
with both exposures. S is the excess risk from both expo-
sures when there is an additive interaction, relative to the
risk from both exposures without an interaction. If any of
the null values (0 in RERI and AP or 1 in S) falls outside
the 95% CI of its respective measurement, then the addi-
tive interaction is considered statistically significant.
Details of the method for the calculation of the additive
interaction have been described by Andersson et al. [16].
Excluding the calculation of linkage disequilibrium, all
computations were performed using STATA/SE software
version 11.0 (StataCorp, College Station, TX, USA).
Results
Compared with control subjects, women with rhinocon-
junctivitis were more likely to live in prefectures other
than Fukuoka Prefecture on Kyushu Island and to have a
family history of allergic rhinitis, and were less likely to
live in Okinawa Prefecture and to have one or more older
siblings (Table 1). There were no differences between
cases and control subjects with regard to age, smoking,
and education.
The distributions of IL13 SNPs rs1800925 and rs20541
among control subjects were in Hardy-Weinberg equili-
brium (P = 0.54 and 0.11, respectively). SNP rs1800925
showed a high linkage disequilibrium value with SNP
rs20541 (D’ = 0.84).
Compared with the CC genotype of SNP rs1800925,
neither the CT nor the TT genotype was significantly
associated with the risk of rhinoconjunctivitis (Table 2).
No significant relationship was observed between the
combination of CT and TT genotypes of rs1800925 and
rhinoconjunctivitis. On the other hand, the frequency of
the AA genotype of SNP rs20541 was 10.9% in cases and
7.1% in control subjects. Using women with the GG gen-
otype as a reference group, those with the AA genotype
had a significantly increased risk of rhinoconjunctivitis,
whereas the GA genotype was not associated with the
risk of rhinoconjunctivitis in crude analysis. After adjust-
ment for age, region of residence, presence of older
Table 1 Characteristics of the study population
n (%) or mean (SD)
Variable Cases
(N = 393)
Controls
(N = 767)
P value*
Age (years) 31.4 (4.2) 31.3 (4.3) 0.73
Region of residence (%) 0.01
Fukuoka Prefecture 221 (56.2) 438 (57.1)
Other than Fukuoka Prefecture in Kyushu 148 (37.7) 245 (31.9)
Okinawa Prefecture 24 (6.1) 84 (11.0)
Presence of one or more older siblings (%) 181 (46.1) 419 (54.6) 0.006
Having ever smoked (%) 125 (31.8) 224 (29.2) 0.36
Family history of allergic rhinitis (%) 224 (57.0) 248 (32.3) < 0.0001
Education (% years) 0.66
< 13 93 (23.7) 168 (21.9)
13 - 14 133 (33.8) 253 (33.0)
≥ 15 167 (42.5) 346 (45.1)
* c
2 test or t test.
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education, the positive association between the AA geno-
type and rhinoconjunctivitis remained: the adjusted OR
was 1.65 (95% CI: 1.05 - 2.60). Nevertheless, there was no
significant relationship between the GA and AA geno-
types combined and rhinoconjunctivitis.
In a sensitivity analysis restricted to cases with doctor-
diagnosed allergic rhinitis (n = 293), the results were
similar to those observed in the overall analysis (Table 3).
The adjusted OR for the AA genotype of SNP rs20541
was 1.66 (95% CI: 1.004 - 2.75).
The haplotype containing the rs1800925 C allele and the
rs20541 A allele was significantly associated with an
increased risk of rhinoconjunctivitis, as compared with all
other haplotypes combined (Table 4). The other haplo-
types were not related to rhinoconjunctivitis.
A positive relationship between the TT genotype of
SNP rs1800925 and rhinoconjunctivitis was detected in
women who had a history of smoking, but not in those
who had never smoked, although this positive relation-
ship was not statistically significant (Table 5). A positive
association between the AA genotype of SNP rs20541
and rhinoconjunctivitis was more pronounced in women
who had smoked than in those who had never smoked;
nevertheless, the positive associations were not signifi-
cant regardless of smoking status. There were no signifi-
cant multiplicative interactions between the SNP
rs1800925 or rs20541 and smoking with regard to
rhinoconjunctivitis.
Based on the recessive model, the additive interactions
between IL13 SNPs and smoking were examined (Table 6).
Compared with women with the CC or CT genotype of
SNP rs1800925 who had never smoked, those with the TT
genotype who had ever smoked had a 2.67-fold increased
risk of rhinoconjunctivitis, although the adjusted OR was
not significant. The estimated AP, however, was statistically
significant (AP = 0.71, 95% CI: 0.25 - 1.18), though RERI
and S were not. Compared with women with the GG or
Table 2 Odds ratios (ORs) and 95% confidence intervals (CIs) for rhinoconjunctivitis according to IL13 polymorphisms
in Japanese women, KOMCHS, Japan
SNP Genotype Cases n (%) Controls n (%) Crude OR (95% CI) Adjusted OR (95% CI)*
rs1800925 (N = 393) (N = 767)
Model 1 CC 270 (68.7) 516 (67.3) 1.00 1.00
CT 110 (28.0) 230 (30.0) 0.91 (0.70 - 1.20) 0.94 (0.71 - 1.25)
TT 13 (3.3) 21 (2.7) 1.18 (0.58 - 2.40) 1.10 (0.53 - 2.28)
Model 2 CC 270 (68.7) 516 (67.3) 1.00 1.00
CT + TT 123 (31.3) 251 (32.7) 0.94 (0.72 - 1.22) 0.96 (0.73 - 1.26)
rs20541 (N = 393) (N = 766)
Model 1 GG 185 (47.1) 379 (49.5) 1.00 1.00
GA 165 (42.0) 333 (43.5) 1.02 (0.79 - 1.31) 1.03 (0.79 - 1.34)
AA 43 (10.9) 54 (7.1) 1.63 (1.05 - 2.53) 1.65 (1.05 - 2.60)
Model 2 GG 185 (47.1) 379 (49.5) 1.00 1.00
GA + AA 208 (52.9) 387 (50.5) 1.10 (0.86 - 1.40) 1.12 (0.86 - 1.44)
* Adjusted for age, region of residence, presence of older siblings, smoking, family history of allergic rhinitis, and education.
Table 3 Odds ratios (ORs) and 95% confidence intervals (CIs) for doctor-diagnosed allergic rhinitis according to IL13
polymorphisms in Japanese women, KOMCHS, Japan
SNP Genotype Cases n (%) Controls n (%) Crude OR (95% CI) Adjusted OR (95% CI)*
rs1800925 (N = 293) (N = 767)
Model 1 CC 201 (68.6) 516 (67.3) 1.00 1.00
CT 84 (28.7) 230 (30.0) 0.94 (0.70 - 1.26) 0.97 (0.71 - 1.33)
TT 8 (2.7) 21 (2.7) 0.98 (0.43 - 2.24) 0.89 (0.38 - 2.13)
Model 2 CC 201 (68.6) 516 (67.3) 1.00 1.00
CT + TT 92 (31.4) 251 (32.7) 0.94 (0.70 - 1.26) 0.96 (0.71 - 1.30)
rs20541 (N = 293) (N = 766)
Model 1 GG 135 (46.1) 379 (49.5) 1.00 1.00
GA 126 (43.0) 333 (43.5) 1.06 (0.80 - 1.41) 1.08 (0.80 - 1.46)
AA 32 (10.9) 54 (7.1) 1.66 (1.03 - 2.69) 1.66 (1.004 - 2.75)
Model 2 GG 135 (46.1) 379 (49.5) 1.00 1.00
GA + AA 158 (53.9) 387 (50.5) 1.15 (0.88 - 1.50) 1.16 (0.88 - 1.55)
* Adjusted for age, region of residence, presence of older siblings, smoking, family history of allergic rhinitis, and education.
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those with the AA genotype who had ever smoked showed
a significantly increased risk of rhinoconjunctivitis,
although the additive interaction was not significant.
Discussion
The current study found that, compared with the GG
genotype of IL13 SNP rs20541, the AA genotype, occur-
ring in 7.1% of control subjects, was significantly posi-
tively related to the risk of rhinoconjunctivitis, whereas
t h eG Ag e n o t y p ea n dt h eG Aa n dA Ag e n o t y p e sc o m -
bined were not associated with rhinoconjunctivitis. In
contrast, IL13 SNP rs1800925 was not materially related
to the risk of rhinoconjunctivitis. Haplotype analyses
found a significant positive relationship between the hap-
lotype carrying the rs1800925 C allele and the rs20541 A
allele, occurring in 12.6% of control subjects, and the risk
of rhinoconjunctivitis. The multiplicative interactions
between the two SNPs under study and smoking did not
have a statistically significant effect on the risk of rhino-
conjunctivitis. Based on the recessive model, however,
the additive interaction between SNP rs1800925, but not
rs20541, and smoking was significant, as the AP value
indicates.
A case-control study of Korean young adults found a
significant positive association between the rs20541 A
allele and allergic rhinitis, whereas the positive relation-
ship between the AA genotype and allergic rhinitis was
of borderline significance [7]. In a case-control study in
Japan, on the other hand, SNP rs20541 was not related
to the risk of Japanese cedar pollinosis [8]. No signifi-
cant association was observed between SNP rs20541 and
hay fever in a case-control study of German adults [9].
Neither SNP rs1800925 nor rs20541 was associated with
hay fever or allergic rhinitis in studies in the UK [5],
Spain [6], and China [10]. These inconsistent results
may be at least partly explained by differences in the
genetic backgrounds of the populations examined, defi-
nitions of allergic rhinitis, and statistical power. Yet
when the data from these six studies [5-10] were com-
bined in a meta-analysis, they indicated a significant
positive association between the rs20541 A allele and
allergic rhinitis (overall OR using a fixed-effect model =
1.18 [95% CI: 1.05 - 1.31]), and no association between
SNP rs1800925 and allergic rhinitis (overall OR using a
fixed-effect model = 1.09 [95% CI: 0.94 - 1.27]) [11].
The current findings are in agreement with the results
of this meta-analysis.
Table 4 Haplotype analysis of rs1800925 and rs20541 in relation to rhinoconjunctivitis in Japanese women, KOMCHS,
Japan
Haplotype Haplotype structure Frequency n (%)
number rs1800925 rs20541 Cases (2N = 786) Controls (2N = 1534) Crude OR (95% CI)*
1 C G 516 (65.6) 1068 (69.6) 0.83 (0.69 - 1.01)
2 C A 134 (17.0) 194 (12.6) 1.42 (1.11 - 1.81)
3 T G 19 (2.4) 25 (1.6) 1.50 (0.77 - 2.84)
4 T A 117 (14.9) 247 (16.1) 0.91 (0.71 - 1.16)
* Crude OR for each haplotype is relative to all other haplotypes combined.
Table 5 Association between IL13 polymorphisms and rhinoconjunctivitis, stratified by smoking status in Japanese
women, KOMCHS, Japan
Smoking status
No Yes
SNP Genotype No. cases/controls Adjusted OR (95% CI)* No. cases/controls Adjusted OR (95% CI)* P for interaction
rs1800925
Model 1 CC 185/370 1.00 85/146 1.00
CT 75/156 1.08 (0.76 - 1.52) 35/74 0.76 (0.46 - 1.25) 0.30
TT 8/17 0.75 (0.30 - 1.87) 5/4 2.48 (0.63 - 9.74) 0.17
Model 2 CC 185/370 1.00 85/146 1.00
CT + TT 83/173 1.04 (0.74 - 1.45) 40/78 0.84 (0.52 - 1.35) 0.53
rs20541
Model 1 GG 129/275 1.00 56/104 1.00
GA 113/227 1.16 (0.84 - 1.60) 52/106 0.82 (0.50 - 1.34) 0.28
AA 26/40 1.46 (0.83 - 2.56) 17/14 2.10 (0.94 - 4.67) 0.37
Model 2 GG 129/275 1.00 56/104 1.00
GA + AA 139/267 1.20 (0.88 - 1.64) 69/120 0.98 (0.62 - 1.55) 0.52
* Adjusted for age, region of residence, presence of older siblings, family history of allergic rhinitis, and education.
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AA genotype of SNP rs20541 had significantly higher
levels of serum IL-13 than those with the GG genotype
[17]. Another study in Japan found that the IL-13 Glu110
variant had a lower affinity with IL-13Ra2 than with wild-
type IL-13, causing less clearance and enhanced stability
in plasma [18]. Vladich et al. have shown that the IL-13
Glu110 variant is significantly more active than wild-type
IL-13 in inducing STAT6 phosphorylation and CD23
expression in primary human monocytes and hydrocorti-
sone-dependent IgE switching in human B cells [19]. That
paper also reported that a soluble form of IL-13Ra2 neu-
tralized wild-type IL-13 more effectively than it did the
IL-13 Glu110 variant [19]. A study in the Netherlands
observed that the TT genotype of SNP rs1800925 was sig-
nificantly associated with reduced inhibition of IL-13 pro-
duction by anti-CD2, compared with the CT or CC
genotype [20]. Cameron et al. have shown that the T allele
of SNP rs1800925 increased IL13 transcription in primary
human and murine CD4
+ Th2 lymphocytes through Yin-
Yang 1-dependent attenuation of STAT6-mediated pro-
moter repression, and that mitogen-activated peripheral
blood mononuclear cells from pregnant women with the
TT genotype of SNP rs1800925 secreted significantly
higher levels of IL-13 compared with those from pregnant
women with the CC or CT genotype [21].
To our knowledge, the current study is the first to find a
significant additive interaction between IL13 SNP
rs1800925 and smoking that affects the risk of rhinocon-
junctivitis, indicating a biological interaction, although the
multiplicative interaction was not significant. Two risk fac-
tors are considered to engage in a biological interaction if
they are involved in the same sufficient cause [22]. When
the risk factors are independent and do not interact in a
biological way, they are considered to have an additive
effect [22]. The degree of a biological interaction between
risk factors is measured as the difference between the
observed effect and the expected additive effect of the
interacting risk factors [22]. A previously cited study of
UK adults observed a significant interaction between SNP
rs1800925 and smoking with respect to allergy, but not
with respect to asthma or hay fever: the relationship
between SNP rs1800925 and allergy was stronger among
smokers than among nonsmokers [5]. In the other 5 pre-
viously cited studies that have investigated IL13 SNPs and
allergic rhinitis, gene-environment interactions were not
examined [6-10]. In a study in Germany, children with the
TT genotype of SNP rs1800925 or the AA genotype of
SNP rs20541 who were exposed to postnatal maternal
smoking had higher total serum IgE levels than similar
children who were not exposed to maternal smoking, with
statistically significant interactions between the IL13 var-
iants and maternal smoking [23]. These results are in par-
tial agreement with our findings. In contrast, a study of
UK children revealed a significant interaction between
SNP rs20541 and perinatal smoking exposure on the risk
of early-onset persistent wheeze: the risk was most evident
in children with the major GG genotype who were
exposed to perinatal smoking [24].
The methodological strengths of this study include the
homogeneity of study subjects in that they were all preg-
nant women, and the consideration of several confounders.
Several limitations also warrant mention. First, the par-
ticipation rate cannot be calculated because the exact
Table 6 Additive interaction between IL13 polymorphisms and smoking
Smoking status
No Yes
SNP Adjusted OR (95% CI)* Adjusted OR (95% CI)*
rs1800925
CC + CT 1.00 0.98 (0.74 - 1.31)
TT 0.78 (0.32 - 1.89) 2.67 (0.70 - 10.17)
Measures of additive interaction
†
Relative excess risk due to interaction (RERI) = 1.90 (95% CI: -1.71 - 5.52)
Attributable proportion due to interaction (AP) = 0.71 (95% CI: 0.25 - 1.18)
Synergy index (S) = -6.97 (95% CI: not calculable)
rs20541
GG + GA 1.00 0.96 (0.71 - 1.29)
AA 1.34 (0.78 - 2.29) 2.34 (1.10 - 4.98)
Measures of additive interaction
†
Relative excess risk due to interaction (RERI) = 1.05 (95% CI: -0.82 - 2.91)
Attributable proportion due to interaction (AP) = 0.45 (95% CI: -0.07 - 0.96)
Synergy index (S) = 4.52 (95% CI: 0.25 - 83.47)
* Adjusted for age, region of residence, presence of older siblings, family history of allergic rhinitis, and education.
† Statistically significant with the 95% CI of RERI > 0, the 95% CI of AP > 0, or the 95% CI of S > 1, indicating additive interaction.
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with the abovementioned KOMCHS documents is not
available. In addition, we were not able to assess differ-
ences between participants and non-participants, because
information on personal characteristics such as age,
socioeconomic status, and a history of allergic disorders
among the non-participants was not available. Our sub-
jects were probably not representative of Japanese
women in the general population: for example, the distri-
bution of educational status among participants differed
considerably from that among the general population.
According to the 2000 population census of Japan, the
proportions of women aged 30 to 34 years in Fukuoka
Prefecture with years of education of < 13, 13 - 14, ≥ 15,
and unknown were 52.0%, 31.5%, 11.8%, and 4.8%,
respectively [25]. The corresponding figures for the cur-
rent study in the control group were 21.9%, 33.0%, 45.1%,
and 0.0%, respectively. Therefore, the present population
might have had greater awareness concerning health-
related matters compared to the general population.
Although selection bias occurred, the distribution of the
2 SNPs under study in the control group was in agree-
ment with the Hardy-Weinberg equilibrium.
Second, the definition of rhinoconjunctivitis was based
on the questions in the ISAAC questionnaire. Validation
tests of such questions have not been performed for Japa-
nese young adults. Data on serum-specific IgE levels were
not available. It is assumed that some proportion of cases
may be misclassified, which could cause bias toward the
null. However, the results of the sensitivity analysis con-
fined to cases with doctor-diagnosed allergic rhinitis (n =
293) were similar to those in the overall analysis.
Third, the current study size, especially the number of
cases, was rather small for a valid genetic association
study. Although a significant association between SNP
rs20541 and rhinoconjunctivitis and a significant additive
interaction between SNP rs1800925 and smoking were
identified, the insignificant additive interaction between
SNP rs20541 and smoking might be attributable to insuffi-
cient statistical power in the current study.
Fourth, correction for multiple testing was not per-
formed in this study. As this is a hypothesis testing study
and part of the current findings is a replication of pre-
viously published results, we think that correction for mul-
tiple testing would cause us to underestimate our results.
Despite this background, it should be noted that our find-
ings might reflect a chance phenomenon, and that future
studies will be needed to replicate the current new findings.
Conclusions
The present case-control study of Japanese women
showed that the AA genotype of IL13 SNP rs20541 and
the haplotype comprising the rs1800925 C allele and the
rs20541 A allele were significantly positively associated
with the risk of rhinoconjunctivitis. Also, a new pattern
of biological interaction that affects the risk of rhinocon-
junctivitis is described between SNP rs1800925 and
smoking. The current results, however, may not be gen-
eralizable to other populations. Given the strong epide-
miological evidence supporting an environmental effect
of smoking and our statistical suggestion of an interac-
tion, further investigation is warranted to establish a
biological mechanism of interaction.
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